文献速递皮肤肿瘤湿疹皮炎与荨麻疹

非节段型白癜风外周免疫细胞单细胞染色质与转录组综合图谱

Comprehensive single-cell chromatin and transcriptomic profiling of peripheral immune cells in nonsegmental vitiligo.
PubMed 文献 · Br J Dermatol · 2025-01-01

该研究对非节段型白癜风患者(n=11)与健康对照(n=5)的外周血单个核细胞进行单细胞RNA测序与单细胞ATAC测序整合分析,并在扩大队列(患者n=16,对照n=9)中用光谱流式细胞术验证。结果显示以细胞毒性、抗原提呈、耗竭和应激为特征的广泛免疫激活,Th1/Th17极化及Treg/mTreg功能失调,OX40/OX40L轴为潜在治疗靶点。

要点

  • NSV患者外周免疫细胞呈广泛激活,以单核细胞、NK细胞、CD8+ T细胞和树突状细胞为主。
  • 多组学整合揭示Th1/Th17极化及Treg/mTreg功能失调,OX40/OX40L轴放大炎症。
  • 疾病活动度和较短病程与更显著的免疫失调相关。

核心结论

  • NSV存在由细胞毒性、抗原提呈、耗竭和调节功能失败驱动的系统性免疫失调。
  • 疾病严重程度、活动度和病程影响上述通路,OX40/OX40L轴为潜在治疗靶点。

研究设计与样本

  • 对NSV患者(n=11)和健康对照(n=5)的PBMCs进行scRNAseq/scATACseq整合分析。
  • 在扩大队列(NSV n=16,健康对照 n=9)中用光谱流式细胞术验证,并按性别、年龄、疾病活动度、严重程度和病程分层。

主要发现

  • 分析59 192个PBMCs,在25种免疫细胞亚型中鉴定出8204个基因表达标志物和13 925个ATAC峰。
  • 观察到以细胞毒性、抗原提呈、细胞耗竭和应激为特征的广泛激活免疫反应,主要见于单核细胞、NK细胞、CD8+ T细胞和树突状细胞。
  • 多组学整合揭示Th1/Th17极化和Treg/mTreg功能失调。
  • 染色质可及性显示FOXO3、Sp1、AP-1、STAT1/STAT3、IRF1和IRF4的转录因子结合位点富集。
  • 流式细胞术验证显示疾病活动度和较短病程与免疫失调加重相关;CLA+皮肤归巢Th1/Th17极化CD4+ T细胞、CD8+ T细胞和mTregs呈持续激活,以基线PD1+表达为标志。

关键数值与推荐

  • mTregs的IL-4和IL-13产生减少在中重度及活动性疾病中突出。
  • OX40/OX40L介导的单核细胞与效应T细胞间相互作用放大炎症。
  • 强T细胞受体激活驱动Th1/Th17极化并升高CD4+和CD8+ T细胞中IFN-γ和TNF-α产生。

临床怎么用

  • 本研究不改变当前治疗,但提示OX40/OX40L轴可作为减轻免疫失调和复发风险的潜在靶点。
  • 疾病活动度和较短病程与更显著免疫失调相关,提示早期干预可能重要。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nonsegmental vitiligo (NSV) is an autoimmune condition characterized by melanocyte loss. While skin-specific mechanisms have been well studied, systemic immune dysregulation contributing to NSV pathogenesis remains unclear. OBJECTIVES: To use a multi-omic single-cell approach to investigate circulating immune cells in NSV, integrating transcriptional and chromatin accessibility data. METHODS: An integrative single-cell RNA sequencing (scRNAseq)/single-cell assay for transposase-accessible chromatin sequencing (scATACseq) analysis was conducted on peripheral blood mononuclear cells (PBMCs) from people with NSV (n = 11) and healthy control participants (n = 5), identifying transcriptional markers, cell-cell interactions, chromatin accessibility and transcription factor (TF) dynamics. Key findings were validated in an expanded cohort (patients with NSV, n = 16; healthy controls, n = 9) using spectral flow cytometry, with additional stratification by sex, age, disease activity, severity and duration. RESULTS: Analysis of 59 192 PBMCs identified 8204 gene expression markers and 13 925 ATAC peaks across 25 immune cell subtypes. A broadly activated immune response was observed, characterized by cytotoxicity, antigen presentation, cell exhaustion and stress, predominantly in monocytes, natural killer cells, CD8+ T cells and dendritic cells. Multi-omic integration revealed T helper (Th)1/Th17 polarization and dysfunctional regulatory T cell [Treg/memory Treg (mTreg)] responses. Chromatin accessibility highlighted enriched TF binding sites for forkhead box O3 (FOXO3), Sp1, activator protein 1 (AP-1), signal transducer and activator of transcription (STAT)1/STAT3, interferon regulatory factor (IRF)1 and IRF4, regulating pathways linked to cytotoxicity, antigen processing, nuclear factor-κB, Toll-like receptor and Janus kinase/STAT signalling. Flow cytometry validated these findings, showing that disease activity and shorter duration were associated with heightened immune dysregulation. Robust T-cell receptor activation drove Th1/Th17 polarization and elevated interferon-γ and tumour necrosis factor-α production in CD4+ and CD8+ T cells. Cutaneous lymphocyte-associated antigen (CLA)+ skin-homing Th1/Th17-polarized CD4+ T cells, CD8+ T cells and mTregs exhibited persistent activation, marked by basal programmed cell death protein 1 (PD1)+ expression. OX40/OX40L-mediated interactions between monocytes and effector T cells amplified inflammation. Regulatory dysfunction, including reduced interleukin (IL)-4 and IL-13 production by mTregs, was prominent in moderate-to-severe and active disease. CONCLUSIONS: This is the first multi-omic single-cell study of PBMCs from people with NSV, revealing systemic immune dysregulation driven by cytotoxicity, antigen presentation, exhaustion and regulatory failure. Disease severity, activity and evolution influence these pathways, highlighting the OX40/OX40L axis as a potential therapeutic target to mitigate immune dysregulation and relapse risk. Vitiligo is a common condition that causes patches of white skin. This happens because the immune system mistakenly attacks the cells responsible for skin colour. These cells are called ‘melanocytes’. Non-segmental vitiligo (‘NSV’ for short) is the most common form and can spread across the body over time. In this study, researchers from Spain and the USA looked at how the immune system contributes to NSV. We examined immune cells circulating in the blood of people with NSV. Using advanced techniques, we looked at gene activity and DNA structure in these cells. This approach helped us identify which genes and pathways might cause immune cells to attack skin cells. The results showed that specific immune cells were very active. They also showed signs of inflammation and stress, leading to an aggressive immune response. We also found that some immune cells were not functioning in the right way. A key finding was that a specific pathway involving proteins called ‘OX40’ and ‘OX40L’ could drive this imbalance in the immune system. Future treatments could use this pathway to stop the immune system from attacking the skin’s pigment cells. It could also reduce disease progression. This research doesn’t change treatments right now, but it could lead to new and better treatments for people with vitiligo in the future.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Gay-Mimbrera J, Lozano-Ojalvo D, Gómez-Arias PJ, et al. Comprehensive single-cell chromatin and transcriptomic profiling of peripheral immune cells in nonsegmental vitiligo. Br J Dermatol. 2025. PMID: 39888372. doi:10.1093/bjd/ljaf041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。